Shortly after unveiling a $400 million upgrade at its campus in Hillerød, Denmark, Novo Nordisk is reinforcing ... which has often focused on building out capacity for the company’s GLP-1 ...

Novo Nordisk, already active in capital improvements to add manufacturing capacity to meet growing demand for its metabolic medicines, is now building infrastructure for the production of rare ...

Novo Nordisk NOVO.B-1.84%decrease; red down pointing triangle plans to invest $1.2 billion in a new production site for rare-disease medicines in Denmark. The Danish pharmaceutical giant said it ...

Novo Nordisk (NVO) is making headlines with its inventive investment of $1.2 billion aimed at building a new production facility in Odense, Denmark. The scheme will be the first plant built in its ...

But, Denmark is also home to what is suddenly Europe's largest company—Novo Nordisk ... Jon Wertheim: So your next building ...